BioMarin Pharma (BMRN) Tops Q1 EPS by 43c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $68.53 --0%
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $1.13, $0.43 better than the analyst estimate of $0.70. Revenue for the quarter came in at $745 million versus the consensus estimate of $741.02 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Evolv Technology adds 70 customers in Q2, expands bag screening
- Boost Run posts Q2 revenue of $31.1M, up 270% year over year
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
